About BARDA Industry Day


November 7-8, 2017

8:00 AM to 5:00 PM Daily

Washington, D.C.

1300 Pennsylvania Avenue NW


& Breakout Sessions

The Biomedical Advanced Research and Development Authority (BARDA) and the Office of Acquisitions Management, Contracts and Grants (AMCG), components of the U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR), invite you to participate in our annual conference at which you can learn about U.S. Government medical countermeasure requirements, interact with BARDA and AMCG staff, and network with private sector colleagues working in this space.

For more information please visit ASPR (HTML), BARDA (HTML), and AMCG (HTML).

Conference participants will learn about:

  • The past, present, and future of BARDA, what has been accomplished and what remains to be accomplished to ensure preparedness against outstanding threats
  • BARDA's strategy, goals, and areas of interest for FY18 and beyond
  • BARDA Program updates in Influenza and CBRN threat areas
  • Updates and details about BARDA‚Äôs Broad Agency Announcements
  • Challenges of dealing with emerging, as well as current, infectious diseases
  • BARDA Core Services that can support product development and manufacturing
  • Building a national medical response infrastructure, and updates on responses to recent public health emergencies
  • New initiatives and future directions for BARDA
  • Opportunities to develop medical countermeasures for both government and commercial markets
  • Roles and responsibilities of BARDA, AMCG, and private sector partners in contract administration and performance

Presented By


Contact Us

Question or concerns:

Connect With Us

Website Refresh - www.medicalcountermeasures.gov is pleased to announce a phased launch of our newly redesigned public website. We are making website improvements to provide a more modern and customer-centric web experience. Over the next several months you will see differences throughout the site while we continue implementing updates. Thank you for your understanding and please let us know if you have any questions: techwatchinbox@hhs.gov